POZ - Treatment News : New HIV Drug Discovery
Subscribe to:
POZ magazine E-newsletters
POZ Personals Sign In / Join
Username:
Password:

Back to home » Treatment News » May 2008

Web Exclusives

Wafaa El-Sadr: A “Genius” AIDS Research Pioneer

Looking Back, Moving Forward: Reflections on USCA

Claudia Medina: Fighting for Latino People With HIV

» More

Most Talked About

A 'Functional' Cure for HIV? (17)

Only Took Me 23 Years... (blog) (15)

The State of AIDS in Puerto Rico (13)

Politicians Urge Bush for Final Repeal of HIV Travel Ban (11)

HIV-Positive People Living Longer Than Ever Before (10)

TGI Friday’s Fined for Firing HIV-Positive Employee (9)

What's That Mean?
(just double-click it!)

NEW! If you don't understand one of the words in this article, just double-click it. A window will open with a definition from CancerWEB's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:


Most Popular Lessons

The HIV Life Cycle

Herpes Simplex Virus

Human Papilloma Virus (HPV)

Shingles

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

10 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailrssprint

May 20, 2008

New HIV Drug Discovery

In their discovery of a new way to inhibit formation of HIV’s protease enzyme, scientists may have identified a new drug target, according to new data published in the August 2008 issue of Biopolymers and reported today by ScienceDaily.

Protease is a doughnut-shaped enzyme involved in processing viral proteins and assembling them into new infectious viruses. It is currently the target of a handful of drugs called protease inhibitors, all of which bind to and block the hole in the doughnut shape.

Heather Carlson, PhD, a professor of chemistry at the University of Michigan, and her colleagues used computer models of the protease enzyme to discover a new part of the enzyme’s structure that would be vulnerable to chemical inhibition. They found that before the protease assumes its doughnut shape, two ends have to bind together to close the circle. Where these two flaps join is the site that Carlson’s team chose to focus on.

Using their computer models, they developed a chemical inhibitor that was successful at stopping the two ends from joining and the enzyme from maturing into its final shape. The chemical inhibitor they developed is too weak to work as a drug in the human body, but Carlson’s discovery does offer a potential new target for drug development.

Search: Heather Carlson, University of Michigan, Biopolymers, protease


Scroll down to comment on this story.

emailrssprint


Name: (2-50 characters)
Email: (will not show)
City: (optional)

Comment (500 characters left):

(Note: The POZ team review all comments before they are posted. Please do not include either ":" or "@" in your comment.)

| Posting Rules

Previous Comments:

  comments 1 - 2 (of 2 total)    

pablo, Newport Beach, CA, 2008-06-16 09:46:23
A CURE... A medium to STOP the virus. A Key to disrupting and ultimatelly destroying the virus and render it useless. THAT is what we mostly need. We crave the news of such discovery to be done ASAP. Yes Current drugs are life savers and all but we know little about the long term side effects of such chemicals. Even today, under the "best" prescription of drug treatments. We don't know the long time effects of these. A CURE is desperatelly needed. not another drug...

Nate HJohnson, Cincinnati, 2008-05-21 11:37:37
As a consumer of protease inhibitors since 2 days after their widespread release I have great interest in this new development. I am a member of the AIDS Clinical Trials national consumer board the NCAB and have a keen interest in development of new and less toxic drugs to fight, or erradicate HIV. This is exciting news!

comments 1 - 2 (of 2 total)    


[Go to top]

Get Started
Get Answers
What to do if you've just been diagnosed
How to find a support system
Things you should know before starting treatment
How to handle side effects and other concerns
How to tell someone you have HIV/AIDS

Talk to Us
Weekly Poll
Question: Have you ever been tested for TB?
Yes
No

Monthly Poll
Question: Do you think the new American president will effectively address HIV/AIDS issues during his first 100 days?
Yes
No
I don't know

Surveys
Tell us about your travel experiences.

Tell us about your pets.

more surveys  
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertise/contact us | site map]
© 2008 Smart + Strong. All Rights Reserved. Terms of use and Your privacy